Plain-English translation of NCT07768644 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
Pulmonary hypertension is a serious condition where blood vessels in the lungs become narrowed, making it harder for the heart to pump blood. Researchers have noticed that some patients with this condition—especially those with a related condition called systemic sclerosis—also have visible abnormalities in the tiny blood vessels in their fingernails. This study uses a simple microscope imaging technique called nailfold capillaroscopy to take pictures of these fingernail blood vessels before and after patients start pulmonary vasodilator therapy (medications that help widen lung blood vessels) to see if the medication improves these vessel abnormalities.
Doctors know that blood vessel problems are central to pulmonary hypertension, but they don't yet understand whether treating the disease also reverses the blood vessel damage visible in the fingernails. If this medication can improve these visible changes, it might help doctors better track how well treatment is working and predict which patients will do better.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will have your fingernails examined using a special microscope (nailfold capillaroscopy) at the time of your diagnosis or when your doctor decides to increase your treatment. If you are starting new pulmonary hypertension medication, you will be invited back for follow-up nail imaging to see if the tiny blood vessels have changed. The imaging itself is painless and non-invasive—the doctor simply places a special microscope against your fingernail to take pictures. The study involves multiple scanning visits over time as your treatment progresses.
AI-generated summary from trial data · Aug 18, 2026 · Not medical advice
United Kingdom